Tucker Asset Management’s Edwards Lifesciences EW Stock Holding History

Tucker Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21	Closed	-$1.79K	–	588
2025 Q4	$1.79K	Buy	+21	New	+$1.72K	﹤0.01%	874
2025 Q1	–	Sell	-21	Closed	-$1.55K	–	510
2024 Q4	$1.55K	Hold	21	–	–	﹤0.01%	1268
2024 Q3	$1.39K	Hold	21	–	–	﹤0.01%	1228
2024 Q2	$1.94K	Hold	21	–	–	﹤0.01%	1323
2024 Q1	$2.01K	Buy	+21	New	+$1.76K	﹤0.01%	1311
2023 Q4	–	Sell	-3	Closed	-$208	–	1495
2023 Q3	$208	Hold	3	–	–	﹤0.01%	1301
2023 Q2	$283	Hold	3	–	–	﹤0.01%	1070
2023 Q1	$248	Sell	3 -6	-67%	-$472	﹤0.01%	1095
2022 Q4	$677	Hold	9	–	–	﹤0.01%	681
2022 Q3	$652	Buy	+9	New	+$866	﹤0.01%	711
2021 Q2	–	Sell	-300	Closed	-$25.1K	–	350
2021 Q1	$25.1K	Hold	300	–	–	0.01%	119
2020 Q4	$27.4K	Buy	+300	New	+$24.9K	0.02%	101

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Tucker Asset Management's EW Position: Q1 2026 in Review

Tucker Asset Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 21 shares — an estimated $1.79K sold.

Tucker Asset Management first reported a position in EW in Q4 2020 and held it in 12 quarters. The position peaked at $27.4K in Q4 2020. 1,291 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Tucker Asset Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Tucker Asset Management sold 21 Edwards Lifesciences shares in Q1 2026, an estimated $1.79K.
Tucker Asset Management first reported a position in Edwards Lifesciences in Q4 2020 and held it in 12 quarters.
Tucker Asset Management's Edwards Lifesciences position peaked at $27.4K in Q4 2020.
1,291 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.